According to Clinical Trials Today, Canadian contract research organization (CRO) ASKA Research entered into strategic partnerships with two CROs that will expand ASKA’s service offerings in North America and in Australia.
The first partnership, with Queensland, Australia-based Clinical Network Services (CNS), was made possible by the Economic Research Agreement between British Columbia and Queensland, which went into effect last June. The agreement is designed to build international relations in key sectors, such as biotechnology and life sciences.
According to ASKA, the partnership with CNS is the first business-to-business partnership resulting from the intergovernmental alliance.
ASKA also entered into a partnership with Winnipeg, Canada-based Clinical Development Solutions (CDS), which focuses on cardiovascular and metabolic disease areas. ASKA and CDS will provide services to one another and their clients to reduce the time to market and production costs.
With ASKA's partnerships going global, will we see a ripple effect from other CROs?
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
May
(15)
- As Sponsors increasingly look to CROs to provide e...
- Shifting Clinical Trial Environment
- Centralized patient recruitment
- Making the Business Case for Improving your Compar...
- Recession, stimulus bill open new doors for CROs
- Top Five States for Biotech Innovation
- ASKA Partners with International CROs
- Encorium looking for a buyer
- Phase III Clinical Trials
- Bio-Imiging Technologies and Phoenix Data Systems ...
- A Look at the 18th Annual Partnerships with CROs
- CASE STUDY: How Do Mergers, Acquisitions and Licen...
- Leveraging Relationship Structures to Optimize Spo...
- Outsourcing Clinical Trials in Emerging Regions: I...
- How to Make Change Part of Your Competitive Advantage
-
▼
May
(15)
No comments:
Post a Comment